Automate Your Wheel Strategy on OGI
With Tiblio's Option Bot, you can configure your own wheel strategy including OGI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OGI
- Rev/Share 1.504
- Book/Share 3.0266
- PB 0.6296
- Debt/Equity 0.0244
- CurrentRatio 3.4183
- ROIC -0.0509
- MktCap 255127581.7503
- FreeCF/Share -0.2072
- PFCF -9.54
- PE 14.5645
- Debt/Assets 0.0177
- DivYield 0
- ROE 0.0513
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands
Published: May 16, 2025 by: Seeking Alpha
Sentiment: Positive
Organigram Global reported record-high revenues for Q2 and improved net income. The company is now selling cannabis beverages in Canada and hemp-derived cannabis beverages in the US. Organigram Global is ramping up its facilities in Canada to meet international demand.
Read More
Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn
Published: May 12, 2025 by: Benzinga
Sentiment: Positive
Cannabis grower Organigram Holdings Inc OGI reported second-quarter 2025 net sales of $45.7 million (approximately CA$65.6 million). That's up 74% year-over-year, beating the consensus of $42.28 million.
Read More
Organigram Global Inc. (OGI) Q2 2025 Earnings Call Transcript
Published: May 12, 2025 by: Seeking Alpha
Sentiment: Neutral
Organigram Global Inc. (NASDAQ:OGI ) Q2 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Max Schwartz - Investor Relations Beena Goldenberg - Chief Executive Officer Greg Guyatt - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
Read More
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Negative
OrganiGram (OGI) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
Read More
Organigram Reports Record Second Quarter Fiscal 2025 Results
Published: May 12, 2025 by: Business Wire
Sentiment: Neutral
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (“Q2 Fiscal 2025”). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in.
Read More
Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California
Published: May 07, 2025 by: Business Wire
Sentiment: Neutral
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received a gold award for Blood Orange, Yuzu & Vanilla and a platinum award for Mango, Pineapple & Coconut hemp-derived THC b.
Read More
Organigram Global Shares Recording of its OG Investor Session
Published: April 22, 2025 by: Business Wire
Sentiment: Neutral
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), Canada's #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. To access a recording of the event please click here or visit www.organigram.ca/investors. “This session was a way for Organigram to engage directly with investors and industry stak.
Read More
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
Published: March 24, 2025 by: Business Wire
Sentiment: Neutral
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on March 24, 2025 (the “Meeting”). Shareholder Approval of the Name Change and Articles of Amendment At the Meeting, a special resolution approving an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.” (the.
Read More
Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks
Published: February 23, 2025 by: Seeking Alpha
Sentiment: Positive
Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales.
Read More
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
Published: February 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
Read More
Organigram Reports First Quarter Fiscal 2025 Results
Published: February 11, 2025 by: Business Wire
Sentiment: Neutral
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2024 (“Q1 Fiscal 2025”). The Q1 Fiscal 2025 results include the financial results of Motif Labs Ltd. ("Motif") from December 6, 2024 to December 31, 2024, following the Company's acquisition of Motif. Q1 FISCAL 2025 HIGHLIGHTS Net revenue increased 17% to $42.7 million from $36.5 mill.
Read More
About Organigram Global Inc. (OGI)
- IPO Date 2019-05-21
- Website https://www.organigram.ca
- Industry Drug Manufacturers - Specialty & Generic
- CEO Ms. Beena G. Goldenberg
- Employees 1093